RR
RAJENDRA RAUT
Syngene International (India), The University of North Carolina at Chapel Hill School of Medicine
0000-0003-0719-930X
Employment
-
Syngene International (India) Associate Director2020 - Present
-
The University of North Carolina at Chapel Hill School of Medicine Post-Doctoral Research Associate2015 - 2020
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (12)
- The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients Save
- Structural Differences Between Dengue Viruses Circulating in Humans and Viruses Used for Vaccine Research Save
- Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies Save
- A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice. Save
- Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris. Save
- Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes. Save
- Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies. Save
- A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture. Save
- Dengue-specific subviral nanoparticles: design, creation and characterization. Save
- Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies. Save